$0.50
-1.50%
N/A-$0.01
Healthcare
Biotechnology
AMEX
활발히 거래 중
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two ...
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Employee Stock Option (right to buy) | A | 55,900 | $0.59 |
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Common Stock | — | 0 | — |
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Employee Stock Option (right to buy) | — | 10,000 | $0.93 |
| Dec 12, 2025 | Telling Fred | director | Common Stock | D | 210 | $0.94 |
| Dec 12, 2025 | Telling Fred | director | Common Stock | D | 210 | $0.94 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Employee Stock Option (right to buy) | A | 55,900 | $0.59 | $32,981.00 |
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Common Stock | — | 0 | — | — |
| Jul 1, 2026 | Spencer John | officer: Chief Financial Officer | Employee Stock Option (right to buy) | — | 10,000 | $0.93 | $9,300.00 |
| Dec 12, 2025 | Telling Fred | director | Common Stock | D | 210 | $0.94 | $198.37 |
| Dec 12, 2025 | Telling Fred | director | Common Stock | D | 210 | $0.94 | $198.37 |
| Dec 11, 2025 | Huffman Janet | officer: CEO and CFO | Employee Stock Option (right to buy) | A | 250,000 | $0.93 | $232,500.00 |
| Dec 11, 2025 | Giordano Natasha | director | Non-Employee Director Option (Right to Buy) | A | 125,000 | $0.93 | $116,250.00 |
| Dec 11, 2025 | Giordano Natasha | director | Non-Employee Director Option (Right to Buy) | A | 38,320 | $1.03 | $39,469.60 |
| Dec 11, 2025 | Telling Fred | director | Non-Employee Director Option (Right to Buy) | A | 125,000 | $0.93 | $116,250.00 |
| Dec 11, 2025 | GANDOLFO JOHN P | director | Non-Employee Director Option (Right to Buy) | A | 125,000 | $0.93 | $116,250.00 |